In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anika Therapeutics Inc.

www.anikatherapeutics.com

Latest From Anika Therapeutics Inc.

Market Intel: Orthobiologics Market Well-Positioned For Innovative Reconstruction

Global sales of orthobiologics for musculoskeletal soft tissue replacement and regeneration are predicted to hit $1.4bn by 2021, driven largely by rising numbers of sports injuries requiring treatment, but also by a higher prevalence of osteoarthritis and a need for innovative treatments for musculoskeletal repair. This article offers an in-depth look at the orthobiologics market landscape for cartilage, meniscus and ligament/tendon replacement and regeneration, as well as insight from an orthopedic surgeon. It also analyzes key players in these markets and highlights emerging trends and the greatest barriers for wider adoption of products.

Orthopedics Cellular & Genetic

FDA Taps New Office of Device Evaluation Director From Industry

Device industry veteran John Sheets has been appointed as the new director of FDA's premarket review office for devices. It’s the second time this year that CDRH has tapped an industry executive to lead one of its offices.

Medical Device Regulation

Medtech Execs On The Move, May 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Execs On The Move, May 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Anika Therapeutics Inc.
  • Senior Management
  • Joseph Darling, Pres. & CEO
    Cheung Sylvia, CFO
    Dana M Alexander, COO
    John W Sheets, Jr., PhD, CSO
    Richard Hague, Chief Commercial Officer
    James Loerop, EVP, Bus. Dev. & Strategic Planning
  • Contact Info
  • Anika Therapeutics Inc.
    Phone: (781) 457-9000
    32 Wiggins Ave.
    Bedford, MA 01730
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register